Business Context and Reporting Period
Company: GlaxoSmithKline plc
Filing Type: Form 6-K (Report of Foreign Issuer)
Reporting Period: October 2011
Date Filed: October 10, 2011
This filing reports a corporate action regarding a blocklisting application submitted to the Financial Services Authority and the London Stock Exchange Plc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notice of a share issuance application and does not contain financial performance data.
Material Changes
The material change reported is the application to admit 20,000,000 ordinary shares of 25p each to the Official List. These shares are reserved under block listings for issuance pursuant to employee share schemes.
Guidance, Outlook, and Management Commentary
The filing contains no guidance, outlook, or management commentary regarding future financial performance. It details the breakdown of the reserved shares:
- GlaxoSmithKline Share Option Plan - Ordinary shares: 10,000,000
- GlaxoSmithKline Share Option Plan - ADS: 5,000,000
- GlaxoSmithKline Savings Related Share Option Scheme: 5,000,000
Upon issuance, these shares will rank pari passu with existing ordinary shares.
Investor Verification Checklist
- Confirm the final admission of the 20,000,000 shares to the Official List.
- Verify the actual issuance dates and quantities under the specific share option schemes.
- Review the impact of this share issuance on total outstanding share count and potential dilution.